You are here: Home » Companies » News
Business Standard

Rossari to acquire Tristar Intermediates at enterprise value of Rs 120 cr

Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of Rs 120 crore

Rossari Biotech | acquisition | Speciality chemicals

Press Trust of India  |  New Delhi 

Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma

Ltd, a manufacturer, on Sunday announced the of Tristar Intermediates at an enterprise value of Rs 120 crore.

The board of the company has approved the of Tristar Intermediates, a move which will help expand its product portfolio, primarily in the personal care segment, a joint statement said.

As per the agreement and subject to customary closing conditions, Rossari will be acquiring 100 per cent equity share capital of Tristar Intermediates, it added.

"76 per cent of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next three years. The total enterprise value of the transaction is Rs 120 crore," it said.

Rossari plans to fund the investment through cash on the balance sheet and doesn't intend to raise any debt for this .

Established in 1998, Tristar Intermediates operates in the field of Preservatives, Aroma Chemicals, and Home & Personal Care Additives. It has a manufacturing facility at Sarigam, Gujarat, India with a total capacity of 15,000 MTPA and had a turnover of Rs 110.5 crore.

While commenting on the development, Promoter & Executive Chairman Edward Menezes and Promoter & Managing Director Sunil Chari in a joint statement said:" The combined capabilities will provide a strong growth momentum and will enable us to expand further into the high-potential product categories of personal care and home care, among others.

Rossari Biotech, a BSE listed firm, is a Speciality-Chemicals manufacturer offers solutions for home, personal care and performance chemicals (HPPC), Textile and animal health and nutrition (AHN).

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, July 18 2021. 19:19 IST